Aebi Schmidt (AEBI) Q2 2026 Earnings Call Transcript

Aebi Schmidt (AEBI) reported Q2 2026 earnings, highlighting a 16% increase in order intake to $516M and 9.4% organic sales growth. The company secured major contracts, including a $96M walk-in van frame deal in North America and an $11M German motorway contract in Europe. Adjusted EBITDA rose 22% to $42M, with margins improving by 19 basis points. The company remains cautious due to geopolitical uncertainties and supply chain disruptions.

Original reporting
Published Aug 21, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 10:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aebi Schmidt (AEBI) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

Med
01

Why it matters

The company reported double‑digit sales growth, improved EBITDA margins, and several multi‑million dollar contracts, indicating a positive earnings surprise.

02

Market read

Earnings beat and contract wins may boost the stock and benefit peers in the industrial sector.

03

What to watch

Integration risks of The Shyft acquisition and future regulatory changes.

Relevance 6/10Novelty 7/10Timing: post‑Q2 2026 earnings release

Background

Aebi Schmidt presented its Q2 2026 earnings call, highlighting post‑acquisition performance and new contracts.

Market effects

Specialty vehicle sector sees stronger order intake and margin expansion.

North America and Europe show robust demand, supporting regional equities.

Limited to industrial and transportation markets.

Counterpoint

Despite growth, higher material costs and geopolitical risks could pressure margins.

Key entities

  • Aebi Schmidt Group

    Specialty vehicle manufacturer reporting Q2 2026 results.

Related articles

$AEBIMed

Aebi Schmidt Targets CHF 3B Revenue, 13% Margins as Shyft Synergies Build

Aebi Schmidt (NASDAQ:AEBI) aims for CHF 3B revenue and 13% EBITDA margins by 2030, driven by Shyft synergies and growth in goods transport. The company reported a 26% rise in order intake and 22% increase in profitability post-acquisition. It targets CHF 400M-500M in acquired revenue through bolt-on acquisitions and U.S. expansion.

$AEBIMed

Aebi Schmidt Holding AG (AEBI): Results of Operations and Financial Condition

Aebi Schmidt Holding AG (AEBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Aebi Schmidt Group Reports 22% Increase in Adjusted EBITDA, 16% Growth in Order Intake and 9% Increase in Net Sales, Reflecting Strong Order Momentum and Over-Proportional Profitability Improvement Continued strong order momentum, with Q2 2026 Order Intake of $516m,

$CRMMedAI 8/10

Salesforce Just Made AI's Best Case, and the Skeptics' Case, in One Quarter

Salesforce reported a 13% after-hours stock jump, driven by AI-related growth. Key metrics include a 14% increase in contracted revenue to $33.5B and 210% growth in AI/Data ARR to $3.9B. However, $2.53 of the $2.63 EPS beat came from gains on its Anthropic stake, not AI operations. The company launched Claudeforce, integrating Claude AI into its CRM, aiming to position itself as the foundational layer for AI. Investors should watch if bookings growth sustains beyond the accounting gains.

$IRENMed

Iren's Earnings Weren't Groundbreaking, but 2027 Looks Very Promising

Iren (IREN) reported Q4 FY26 revenue of $137.2M, down 26.7% YoY, and a net loss of $684M. The company expects $25B-$30B in capex for FY27 but plans to fund it without diluting shareholders. Iren aims to increase power delivery to 800MW by late 2027 and has secured high-value deals, including a $9.7B Microsoft contract. Horizon 1 delivery in August will boost recurring revenue, with significant growth expected in 2027.

$APPMed

The Historical Record For Buying AppLovin Stock Dips Carries A Warning

AppLovin (APP) shares fell 26% after a rare earnings miss, with management citing a delay in AI model improvements. Historically, buying dips in APP has led to median 44% losses over 12 months. The company maintains strong revenue growth (61% LTM) and cash flow margins (66%), but future performance hinges on meeting Q3 guidance (46-48% YoY growth).